Medicure Inc. (OTCMKTS:MCUJF – Get Free Report)’s share price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.83 and traded as low as $0.79. Medicure shares last traded at $0.79, with a volume of 0 shares trading hands.
Medicure Stock Down 0.4%
The firm’s 50 day moving average price is $0.85 and its two-hundred day moving average price is $0.83. The company has a current ratio of 1.44, a quick ratio of 1.00 and a debt-to-equity ratio of 0.03. The company has a market capitalization of $8.25 million, a P/E ratio of -3.29 and a beta of 1.06.
Medicure (OTCMKTS:MCUJF – Get Free Report) last issued its quarterly earnings results on Wednesday, November 19th. The company reported ($0.09) earnings per share (EPS) for the quarter. The business had revenue of $5.93 million during the quarter. Medicure had a negative net margin of 13.10% and a negative return on equity of 17.91%.
About Medicure
Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.
Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.
Recommended Stories
- Five stocks we like better than Medicure
- Energy Security Is Now National Security – Positioning Is Happening Now
- Gold Is About to Do Something It Hasn’t in 90 Years
- 3 Signs You May Want to Switch Financial Advisors
- The gold chart Wall Street is terrified of…
- Unlocked: Elon Musk’s Next Big IPO
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
